Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2011; 17(11): 1480-1487
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1480
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Overview of the study design. QOL: Quality of life; PPI: Proton pump inhibitor.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Gastrointestinal Symptom Rating Scale scores during the initial treatment (study 1).
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Proportion of subjects without recurrent gastroesophageal reflux disease symptoms after proton pump inhibitor step-down (Study 2 per-protocol population: n = 70).
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Gastrointestinal Symptom Rating Scale scores during maintenance treatment (study 2).